Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001267602-19-000101
Filing Date
2019-07-22
Accepted
2019-07-22 19:41:26
Documents
1
Period of Report
2019-07-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_156383886597403.html 4  
1 FORM 4 wf-form4_156383886597403.xml 4 4023
  Complete submission text file 0001267602-19-000101.txt   5403
Mailing Address 6120 WINDWARD PARKWAY STE 290 ALPHARETTA GA 30005
Business Address 6120 WINDWARD PARKWAY STE 290 ALPHARETTA GA 30005 678-990-5740
ALIMERA SCIENCES INC (Issuer) CIK: 0001267602 (see all company filings)

EIN.: 200028718 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ALIMERA SCIENCES, INC. 6120 WINDWARD PARKWAY, SUITE 290 ALPHARETTA GA 30005
Business Address
Snisarenko John (Reporting) CIK: 0001783264 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34703 | Film No.: 19966636